TolerRx
Latest round
- Series D
Last raised
- Aug 2006
Total raised
- $118M
Investors
- 13
About TolerRx
TolerRx Inc.Founded in 2000, TolerRx Inc. is based in Cambridge, US, and specializes in treatments for autoimmune disorders.5 mn.com primarily operates as a domain sales platform, focusing on providing premium domain names to individuals and businesses looking to establish an online presence.25 per month. This service is targeted towards entrepreneurs, startups, and established companies across various industries that recognize the importance of a strong digital identity.com addresses the need for memorable and relevant web addresses that enhance branding and visibility in the competitive online market. Clients engage in transactions by either paying the full price for the domain or opting for a monthly installment plan, which allows for greater accessibility in acquiring premium domain names without a significant upfront investment. Each domain sold is accompanied by a 30-day money-back guarantee, ensuring customer satisfaction and fostering trust in the transaction process. This model is typical in the domain registration industry, where businesses often seek to secure unique web addresses that align with their branding strategies.TolerRx Inc. The company is focusing on the development of new immunotherapy products aimed at combating autoimmune diseases, with potential launches anticipated over the next few years. Additionally, TolerRx Inc. is exploring opportunities to enter new geographic markets in Europe and Asia by 2025, aiming to broaden its customer base and increase accessibility to innovative treatments.
Who invested in TolerRx
13 investors across 4 rounds
See all investors in TolerRx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TolerRx
Who invested in TolerRx?
TolerRx has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TolerRx raised?
TolerRx has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did TolerRx last raise money?
TolerRx's most recent round on record is a Series D, in Aug 2006.
What does TolerRx do?
TolerRx is a biotechnology company.
Where is TolerRx headquartered?
TolerRx is headquartered in Cambridge, US.
Which VCs invest in companies like TolerRx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at TolerRx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like TolerRx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.